MedBot seeks commercial edge with dual-use surgical robot
The company’s orthopedic robot is the first domestically developed device to be approved for both hip and knee surgeries Key Takeaways: Even with its latest product, MicroPort MedBot faces intensifying…
2252.HK
Recent Articles
RELATED ARTICLES
- Yunji rides robotics wave to Hong Kong IPO with A-list of backers
- Reducing the cost of commercial humanoid robots
-
BRIEF: MicroPort MedBot raises $35 million in share placement at 20% discount
2252.HK
-
Airdoc Tech enjoys healing properties of medical AI rally
2251.HK
-
Cash-hungry Mabwell seeks financial tonic from Hong Kong investors
688062.SHG
- Cash-strapped Mirxes looks for lifeline in blood-based cancer detection
Discover hidden China stock gems in our weekly newsletter